NIOX Competitors and Similar CompaniesClear all
Affimed N.V.'s competitors and similar companies include Zogenix and Durect.
 Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. | |
Founding Date | Founding Date 2000 | Founding Date 2006 | Founding Date N/A |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Heidelberg, DE HQ | Locations Emeryville, US HQ Maidenhead, GB | Locations Cupertino, US HQ |
Employees | Employees 76 | Employees 743% increase | Employees 902% increase |
Valuation ($) | Valuation ($) 52.5 m | Valuation ($) N/A | Valuation ($) 45.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $2m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $4.8m (FY, 2021) | Cost of goods $78k (FY, 2024) |
Gross profit | Gross profit €13m (FY, 2023) | Gross profit N/A | Gross profit $2m (FY, 2024) |
Net income | Net income (€105.9m) (FY, 2023) | Net income ($227.4m) (FY, 2021) | Net income ($8.3m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Zogenix
HQ
Emeryville, US
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyDurect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View company